A paper appeared during the interim period of time that preceded the RTT-MeCP2 association, which involved MeCP2 in the repression of the retinoblastoma gene [45], and it paved the way in terms of MeCP2’s involvement in cancer. The gene discussed is MECP2; the disease is cancer.